FR2100643B1 - - Google Patents

Info

Publication number
FR2100643B1
FR2100643B1 FR7116742A FR7116742A FR2100643B1 FR 2100643 B1 FR2100643 B1 FR 2100643B1 FR 7116742 A FR7116742 A FR 7116742A FR 7116742 A FR7116742 A FR 7116742A FR 2100643 B1 FR2100643 B1 FR 2100643B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7116742A
Other versions
FR2100643A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2100643A1 publication Critical patent/FR2100643A1/fr
Application granted granted Critical
Publication of FR2100643B1 publication Critical patent/FR2100643B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
FR7116742A 1967-04-14 1971-05-10 Expired FR2100643B1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63080867A 1967-04-14 1967-04-14
US3646670A 1970-05-11 1970-05-11
US59854A US3707474A (en) 1967-04-14 1970-06-26 Certain 4-(4-pyridyl)-5-hydroxy-coumarin intermediates
US00151578A US3726883A (en) 1967-04-14 1971-06-09 2,2-di-and 2,2,3-tri-lower alkyl chroman-and chromen-ols and salts,ethers and esters thereof
US00300443A US3847928A (en) 1967-04-14 1972-10-25 Certain ethers,esters or non-toxic acid addition salt derivatives of 2,2-di-and 2,2,3-tri-lower alkyl chroman-and chromen-ols

Publications (2)

Publication Number Publication Date
FR2100643A1 FR2100643A1 (fr) 1972-03-24
FR2100643B1 true FR2100643B1 (fr) 1975-04-18

Family

ID=27534589

Family Applications (2)

Application Number Title Priority Date Filing Date
FR147747A Expired FR1559520A (fr) 1967-04-14 1968-04-11
FR7116742A Expired FR2100643B1 (fr) 1967-04-14 1971-05-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR147747A Expired FR1559520A (fr) 1967-04-14 1968-04-11

Country Status (9)

Country Link
US (3) US3707474A (fr)
AT (1) AT305281B (fr)
BE (2) BE713490A (fr)
CH (3) CH499541A (fr)
CY (1) CY665A (fr)
DE (2) DE1770171C3 (fr)
FR (2) FR1559520A (fr)
GB (2) GB1162784A (fr)
NL (2) NL156700B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713490A (fr) * 1967-04-14 1968-10-10
BE757454R (fr) * 1969-10-15 1971-04-13 Beecham Group Ltd Composes organiques derivant de pyridylbenzopyrannes, composes intermediaires et procedes pour les
BE758329A (fr) * 1969-10-31 1971-04-30 Beecham Group Ltd Procede de preparation de benzopyranne-5-ols et des coumarines intermediaires en passant par de nouveaux beta- cetoesters
GB1314427A (en) * 1970-07-17 1973-04-26 Beecham Group Ltd Amino acid esters of 2,2-dialkyl-4-4-pyridyl-2h-7-substituted- chromen-5-ols
BE794630A (fr) * 1972-01-26 1973-07-26 Beecham Group Ltd Composes polycycliques antihypertenseurs
US3960880A (en) * 1974-03-26 1976-06-01 Beecham Group Limited Tetrahydropyrid-4-yl-chroman-5-ol derivatives
US3973023A (en) * 1972-01-26 1976-08-03 Beecham Group Limited Anti-hypertensive polycyclic compounds for treating hypertension
GB1417745A (en) * 1973-07-07 1975-12-17 Beecham Group Ltd Chromene compounds
US3947462A (en) * 1974-05-22 1976-03-30 Abbott Laboratories 2,4,7-substituted 5-hydroxy benzopyrans and esters
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
EP1802298B1 (fr) * 2004-10-22 2008-12-31 DSMIP Assets B.V. Nouveaux agents de prevention et de traitement de troubles associes a une neurotransmission deficiente
WO2009150668A1 (fr) * 2008-06-13 2009-12-17 Delhi University Composés de dihydropyridimidinone utilisables dans le traitement de maladies cardiovasculaires et leur procédé de préparation
US20110178168A1 (en) * 2008-06-23 2011-07-21 Virender Singh Parmar Coumarin compounds for the treatment of cardiovascular diseases and a process for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311636A (en) * 1963-03-14 1967-03-28 Upjohn Co Organic chemical compounds and process
BE713490A (fr) * 1967-04-14 1968-10-10

Also Published As

Publication number Publication date
US3707474A (en) 1972-12-26
CH554365A (de) 1974-09-30
FR1559520A (fr) 1969-03-07
CH499541A (de) 1970-11-30
CY665A (en) 1972-12-09
DE1770171C3 (de) 1979-08-30
CH556355A (de) 1974-11-29
DE1770171A1 (de) 1971-09-23
US3726883A (en) 1973-04-10
FR2100643A1 (fr) 1972-03-24
NL7106410A (fr) 1971-11-15
AT305281B (de) 1973-02-26
US3847928A (en) 1974-11-12
DE1770171B2 (de) 1978-12-21
NL156700B (nl) 1978-05-16
GB1162784A (en) 1969-08-27
GB1314428A (en) 1973-04-26
NL6805288A (fr) 1968-10-15
DE2122643A1 (de) 1971-11-25
BE713490A (fr) 1968-10-10
BE766890A (fr) 1971-11-08

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AT298283B (fr)
FR2100643B1 (fr)
AU416737B2 (fr)
AU610966A (fr)
AU1273466A (fr)
AU2256867A (fr)
AU2116667A (fr)
BE509738A (fr)
AU23366A (fr)
AU1677166A (fr)
BE692374A (fr)
AU408412B2 (fr)
BE692332A (fr)
BE692199A (fr)
BE692577A (fr)
BE692654A (fr)
BE692198A (fr)
BE614676A (fr)
BE426053A (fr)
BE609869A (fr)
BE692778A (fr)
BE514578A (fr)
BE692492A (fr)
BE711587A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse